Skip to content
University of Colorado Denver | Anschutz Medical Campus CU Denver | CU Anschutz
  • Webmail
  • UCD Access
  • Canvas
  • Quick Links
 
 

Tools & Resources

  • Campus Directory
  • A-Z Index
  • Human Resources
  • University Policies
  • Auraria Library
  • Strauss Health Sciences Library

Schools & Colleges

CU Denver

  • College of Architecture and Planning
  • College of Arts & Media
  • Business School
  • School of Education & Human Development
  • College of Engineering, Design and Computing
  • College of Liberal Arts and Sciences
  • School of Public Affairs

CU Anschutz Medical Campus

  • School of Dental Medicine
  • Graduate School
  • School of Medicine
  • College of Nursing
  • Skaggs School of Pharmacy and Pharmaceutical Sciences
  • Colorado School of Public Health

CU Campuses

  • CU Anschutz Medical Campus
  • CU Boulder
  • CU Colorado Springs
  • CU Denver
  • CU Online
  • CU System

Announcement: CU Denver is Celebrating 50 Years

Whether you’re an alumnus, current student, member of the faculty and staff, donor, or neighbor, you’re a valuable part of the CU Denver community. Help us celebrate the last 50 years and a future that works for all.

Learn More

SPARK | REACH Colorado

  • Home
  • SPARK Awards
    • What We Fund
    • Application Process
    • Our Funding Sources
    • FAQs
    • Submit an Application
  • Who We Are
    • SPARK Fellows
    • External Review Board
    • SPARK Team
  • Events
    • SPARK Upcoming Events
  • Get Involved
  • Resources
    • SPARK Documents
    • Applicant Supports
  • Contact Us
University Quick Links

SPARK Session 17 | New approaches to drug development and target identification: use of AI

Mar 20, 2019 | 05:00 PM - 07:00 PM
Cost/fee: Free with RSVP
Fulginiti Pavilion for Bioethics and Humanites
13080 East 19th Avenue
Aurora, CO
https://www.nacarchitecture.com/portfolio/UCDFulginiti.html
Email:
SPARKCU@UCDenver.edu
Phone :
303-724-3720
RSVP Here

Presented by: 
Sara Omlid, PhD
Partnering Executive, AtomWise

Sara Omlid, Phd is a Partnering Executive at Atomwise Inc., a biotechnology company in San Francisco that uses artificial intelligence for preclinical drug discovery and development.

Atomwise partners with companies and academic institutions on hit discovery and lead optimization projects. Dr. Omlid manages Atomwise’s successful and rapidly growing Artificial Intelligence Molecular Screen (AIMS) Awards program, which provides AI-powered virtual screening and compounds for testing to over a hundred academic researchers across the world each year.

Prior to joining Atomwise, Dr. Omlid was developing new chemistries to add to the medicinal chemist’s toolbox. She also has experience in management consulting in the biotech and life sciences industry. Dr. Omlid received her PhD and MS in physical organic chemistry as well as her bachelor’s degree in biochemistry from Saint Louis University. 
Add event to:
  • Outlook
  • ICal
  • Google Calendar

CU Innovations

CU Anschutz

Anschutz Health Sciences Building

1890 N Revere Ct

Suite 6202

Mail Stop F411

Aurora, CO 80045


303-724-3720

Twitter
Additional Resources
  • CU Innovations
  • SPARK @ Stanford
  • Other Funding Opportunities
  • Startup in a Box
  • Contact Us
  • Website Feedback
  • CU System
  • Privacy Policy
  • Terms of Use
  • Accessibility
  • Accreditation
  • Employment
  • Give Now
 

© 2023 The Regents of the University of Colorado, a body corporate. All rights reserved.

Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.

CMS Login

Webmail

UCD Access

Canvas

Opens in a new window Opens document in a new window